369 related articles for article (PubMed ID: 15752710)
21. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
22. Mycoplasma contamination alters 2'-deoxyadenosine metabolism in deoxycoformycin-treated mouse leukemia cells.
Plagemann PG; Woffendin C
J Cell Biochem; 1990 Jun; 43(2):161-72. PubMed ID: 2380261
[TBL] [Abstract][Full Text] [Related]
23. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained.
Overgaard-Hansen K; Klenow H
J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409
[TBL] [Abstract][Full Text] [Related]
24. Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis.
Keszler G; Spasokoukotskaja T; Csapo Z; Virga S; Staub M; Sasvari-Szekely M
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1335-42. PubMed ID: 15571254
[TBL] [Abstract][Full Text] [Related]
25. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
[TBL] [Abstract][Full Text] [Related]
27. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
28. Study of the efficacy of a pronucleotide of 2-chloro-2'-deoxyadenosine in deoxycytidine kinase-deficient lymphoma cells.
Bontemps F; Meier C; Delacauw A; Balzarini J; Galmarini C; van den Neste E
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):997-1000. PubMed ID: 17065053
[TBL] [Abstract][Full Text] [Related]
29. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
Simmonds HA; Panayi GS; Corrigall V
Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
[TBL] [Abstract][Full Text] [Related]
31. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
32. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
Kefford RF; Fox RM
Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
[TBL] [Abstract][Full Text] [Related]
33. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: a model for nucleoside kinase action.
Turk B; Awad R; Usova EV; Björk I; Eriksson S
Biochemistry; 1999 Jun; 38(26):8555-61. PubMed ID: 10387103
[TBL] [Abstract][Full Text] [Related]
34. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
[TBL] [Abstract][Full Text] [Related]
35. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Zhang Y; Secrist JA; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
37. Adenosine-mediated killing of cultured epithelial cancer cells.
Barry CP; Lind SE
Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
[TBL] [Abstract][Full Text] [Related]
38. Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure.
Gao X; Blackburn MR; Knudsen TB
Teratology; 1994 Jan; 49(1):1-12. PubMed ID: 8171392
[TBL] [Abstract][Full Text] [Related]
39. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.
Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P
J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2'-deoxycoformycin and deoxyadenosine.
Begleiter A; Verburg L; Israels LG; Johnston JB
Cancer Chemother Pharmacol; 1992; 30(1):65-9. PubMed ID: 1586982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
